Which has higher valuation & earnings, CARL or AORT?

Artivion has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Carlsmed $50.51M 6.19 -$29.63M -$2.51 N/A Artivion $441.33M 2.59 $9.77M $0.24 98.20

Is CARL or AORT more profitable?

Artivion has a net margin of 2.55% compared to Carlsmed's net margin of -57.76%. Artivion's return on equity of 7.15% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Artivion 2.55% 7.15% 3.63%

Which has better valuation and earnings, CNMD or CARL?

CONMED has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 0.77 $47.06M $1.77 19.99 Carlsmed $50.51M 6.19 -$29.63M -$2.51 N/A

Is CNMD or CARL more profitable?

CONMED has a net margin of 4.00% compared to Carlsmed's net margin of -57.76%. CONMED's return on equity of 13.84% beat Carlsmed's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.00% 13.84% 6.05% Carlsmed -57.76% -60.74% -29.84%

Carlsmed (CARL) Competitors

$11.51 +0.27 (+2.37%)

As of 03:05 PM Eastern

Compare

CARL vs. TNDM, AORT, CNMD, AVR, and DRTS

Should you buy Carlsmed stock or one of its competitors? MarketBeat compares Carlsmed with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Carlsmed include Tandem Diabetes Care (TNDM), Artivion (AORT), CONMED (CNMD), Anteris Technologies Global (AVR), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

How does Carlsmed compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Tandem Diabetes Care currently has a consensus target price of $29.13, indicating a potential upside of 83.00%. Carlsmed has a consensus target price of $19.33, indicating a potential upside of 68.03%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, equities analysts plainly believe Tandem Diabetes Care is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Carlsmed has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tandem Diabetes Care	$1.01B	1.07	-$204.71M	-$1.40	N/A
Carlsmed	$50.51M	6.19	-$29.63M	-$2.51	N/A

Tandem Diabetes Care has a net margin of -9.20% compared to Carlsmed's net margin of -57.76%. Tandem Diabetes Care's return on equity of -53.88% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%
Carlsmed	-57.76%	-60.74%	-29.84%

In the previous week, Tandem Diabetes Care had 1 more articles in the media than Carlsmed. MarketBeat recorded 2 mentions for Tandem Diabetes Care and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Tandem Diabetes Care's score of 1.45 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
Tandem Diabetes Care	Positive
Carlsmed	Very Positive

Summary

Tandem Diabetes Care beats Carlsmed on 10 of the 14 factors compared between the two stocks.

How does Carlsmed compare to Artivion?

Carlsmed (NASDAQ:CARL) and Artivion (NYSE:AORT) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

Artivion has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.19	-$29.63M	-$2.51	N/A
Artivion	$441.33M	2.59	$9.77M	$0.24	98.20

86.4% of Artivion shares are owned by institutional investors. 6.3% of Artivion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Carlsmed and Carlsmed both had 1 articles in the media. Carlsmed's average media sentiment score of 1.89 beat Artivion's score of 0.00 indicating that Carlsmed is being referred to more favorably in the media.

Company	Overall Sentiment
Carlsmed	Very Positive
Artivion	Neutral

Carlsmed currently has a consensus target price of $19.33, suggesting a potential upside of 68.03%. Artivion has a consensus target price of $44.17, suggesting a potential upside of 87.40%. Given Artivion's stronger consensus rating and higher possible upside, analysts clearly believe Artivion is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75

Artivion has a net margin of 2.55% compared to Carlsmed's net margin of -57.76%. Artivion's return on equity of 7.15% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Artivion	2.55%	7.15%	3.63%

Summary

Artivion beats Carlsmed on 12 of the 14 factors compared between the two stocks.

How does Carlsmed compare to CONMED?

CONMED (NYSE:CNMD) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, CONMED and CONMED both had 1 articles in the media. Carlsmed's average media sentiment score of 1.89 beat CONMED's score of 0.00 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
CONMED	Neutral
Carlsmed	Very Positive

CONMED currently has a consensus target price of $39.50, suggesting a potential upside of 11.66%. Carlsmed has a consensus target price of $19.33, suggesting a potential upside of 68.03%. Given Carlsmed's stronger consensus rating and higher probable upside, analysts clearly believe Carlsmed is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

CONMED has a net margin of 4.00% compared to Carlsmed's net margin of -57.76%. CONMED's return on equity of 13.84% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.00%	13.84%	6.05%
Carlsmed	-57.76%	-60.74%	-29.84%

CONMED has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.77	$47.06M	$1.77	19.99
Carlsmed	$50.51M	6.19	-$29.63M	-$2.51	N/A

Summary

CONMED beats Carlsmed on 7 of the 12 factors compared between the two stocks.

How does Carlsmed compare to Anteris Technologies Global?

Carlsmed (NASDAQ:CARL) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

In the previous week, Anteris Technologies Global had 2 more articles in the media than Carlsmed. MarketBeat recorded 3 mentions for Anteris Technologies Global and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Anteris Technologies Global's score of 1.06 indicating that Carlsmed is being referred to more favorably in the media.

Company	Overall Sentiment
Carlsmed	Very Positive
Anteris Technologies Global	Positive

Carlsmed currently has a consensus target price of $19.33, suggesting a potential upside of 68.03%. Anteris Technologies Global has a consensus target price of $16.00, suggesting a potential upside of 66.41%. Given Carlsmed's higher probable upside, equities research analysts plainly believe Carlsmed is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Carlsmed has a net margin of -57.76% compared to Anteris Technologies Global's net margin of -5,148.78%. Carlsmed's return on equity of -60.74% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Carlsmed has higher revenue and earnings than Anteris Technologies Global. Carlsmed is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.19	-$29.63M	-$2.51	N/A
Anteris Technologies Global	$1.91M	490.01	-$94.14M	-$2.23	N/A

Summary

Carlsmed beats Anteris Technologies Global on 7 of the 13 factors compared between the two stocks.

How does Carlsmed compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Carlsmed has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A
Carlsmed	$50.51M	6.19	-$29.63M	-$2.51	N/A

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alpha Tau Medical has a net margin of 0.00% compared to Carlsmed's net margin of -57.76%. Carlsmed's return on equity of -60.74% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-73.23%	-52.90%
Carlsmed	-57.76%	-60.74%	-29.84%

In the previous week, Alpha Tau Medical had 6 more articles in the media than Carlsmed. MarketBeat recorded 7 mentions for Alpha Tau Medical and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Alpha Tau Medical's score of -0.02 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Tau Medical	Neutral
Carlsmed	Very Positive

Alpha Tau Medical currently has a consensus price target of $12.60, suggesting a potential upside of 17.05%. Carlsmed has a consensus price target of $19.33, suggesting a potential upside of 68.03%. Given Carlsmed's higher probable upside, analysts clearly believe Carlsmed is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Alpha Tau Medical and Carlsmed tied by winning 7 of the 14 factors compared between the two stocks.

Get Carlsmed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CARL vs. The Competition

Export

Metric	Carlsmed	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$313.39M	$2.92B	$4.35B	$12.18B
Dividend Yield	N/A	N/A	11.51%	5.90%
P/E Ratio	-4.59	14.51	22.03	24.03
Price / Sales	6.19	344.29	202.06	99.66
Price / Cash	N/A	8.09	38.01	53.91
Price / Book	3.09	5.84	13.38	6.31
Net Income	-$29.63M	$7.39M	$115.37M	$337.69M
7 Day Performance	15.06%	-4.41%	-1.45%	-0.94%
1 Month Performance	-3.23%	-9.29%	-2.84%	-0.31%
1 Year Performance	N/A	2.73%	10.80%	25.81%

Carlsmed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CARL Carlsmed	3.1021 of 5 stars	$11.51 +2.4%	$19.33 +68.0%	N/A	$313.39M	$50.51M	N/A	100
TNDM Tandem Diabetes Care	3.2934 of 5 stars	$15.30 flat	$29.84 +95.0%	-18.8%	$1.05B	$1.01B	N/A	2,500	Negative News Analyst Forecast Gap Up
AORT Artivion	4.0659 of 5 stars	$21.18 -0.1%	$44.17 +108.6%	-25.7%	$1.03B	$441.33M	88.23	1,800
CNMD CONMED	2.6418 of 5 stars	$32.59 +0.0%	$39.50 +21.2%	-34.0%	$980.95M	$1.37B	18.41	3,900	High Trading Volume
AVR Anteris Technologies Global	3.4153 of 5 stars	$9.78 flat	$16.00 +63.6%	+149.5%	$952M	$1.91M	N/A	138

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CARL) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Carlsmed (CARL) Competitors

CARL vs. TNDM, AORT, CNMD, AVR, and DRTS

How does Carlsmed compare to Tandem Diabetes Care?

Summary

How does Carlsmed compare to Artivion?

Summary

How does Carlsmed compare to CONMED?

Summary

How does Carlsmed compare to Anteris Technologies Global?

Summary

How does Carlsmed compare to Alpha Tau Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CARL vs. The Competition

Carlsmed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Carlsmed (CARL) Competitors

CARL vs. TNDM, AORT, CNMD, AVR, and DRTS

How does Carlsmed compare to Tandem Diabetes Care?

Do analysts prefer TNDM or CARL?

Which has preferable earnings and valuation, TNDM or CARL?

Is TNDM or CARL more profitable?

Does the media prefer TNDM or CARL?

Summary

How does Carlsmed compare to Artivion?

Which has higher valuation & earnings, CARL or AORT?

Do institutionals & insiders hold more shares of CARL or AORT?

Does the media refer more to CARL or AORT?

Do analysts prefer CARL or AORT?

Is CARL or AORT more profitable?

Summary

How does Carlsmed compare to CONMED?

Does the media refer more to CNMD or CARL?

Do analysts prefer CNMD or CARL?

Is CNMD or CARL more profitable?

Which has better valuation and earnings, CNMD or CARL?

Summary

How does Carlsmed compare to Anteris Technologies Global?

Does the media prefer CARL or AVR?

Do analysts prefer CARL or AVR?

Is CARL or AVR more profitable?

Which has better valuation and earnings, CARL or AVR?

Summary

How does Carlsmed compare to Alpha Tau Medical?

Which has higher valuation & earnings, DRTS or CARL?

Do insiders and institutionals hold more shares of DRTS or CARL?

Is DRTS or CARL more profitable?

Does the media prefer DRTS or CARL?

Do analysts prefer DRTS or CARL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CARL vs. The Competition

Carlsmed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools